ArcticZymes Technologies ASA (AZT.OL)
NOK 16.85
(-0.88%)
NOK 16.85
(-0.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 339.32 Million NOK | 6.36% |
| 2022 | 319.03 Million NOK | 12.29% |
| 2021 | 284.11 Million NOK | 28.03% |
| 2020 | 221.91 Million NOK | 185.94% |
| 2019 | 77.6 Million NOK | 14.11% |
| 2018 | 68.01 Million NOK | 10.26% |
| 2017 | 61.68 Million NOK | -28.14% |
| 2016 | 85.83 Million NOK | -15.08% |
| 2015 | 101.07 Million NOK | -9.05% |
| 2014 | 111.13 Million NOK | 106.64% |
| 2013 | 53.78 Million NOK | 66.83% |
| 2012 | 32.23 Million NOK | -42.89% |
| 2011 | 56.44 Million NOK | -18.17% |
| 2010 | 68.97 Million NOK | -25.19% |
| 2009 | 92.2 Million NOK | -50.9% |
| 2008 | 187.76 Million NOK | -14.47% |
| 2007 | 219.53 Million NOK | 77.41% |
| 2006 | 123.74 Million NOK | -11.98% |
| 2005 | 140.59 Million NOK | 140.0% |
| 2004 | 58.57 Million NOK | -10.55% |
| 2003 | 65.48 Million NOK | 757.74% |
| 2002 | 7.63 Million NOK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 338.95 Million NOK | -1.11% |
| 2024 Q1 | 342.77 Million NOK | 1.02% |
| 2023 Q4 | 339.32 Million NOK | 1.37% |
| 2023 Q2 | 326.98 Million NOK | 2.75% |
| 2023 FY | 339.32 Million NOK | 6.36% |
| 2023 Q1 | 318.23 Million NOK | -0.25% |
| 2023 Q3 | 334.74 Million NOK | 2.37% |
| 2022 Q1 | 293.73 Million NOK | 3.39% |
| 2022 Q3 | 313.43 Million NOK | 2.18% |
| 2022 Q4 | 319.03 Million NOK | 1.79% |
| 2022 FY | 319.03 Million NOK | 12.29% |
| 2022 Q2 | 306.74 Million NOK | 4.43% |
| 2021 FY | 284.11 Million NOK | 28.03% |
| 2021 Q1 | 237.47 Million NOK | 7.01% |
| 2021 Q2 | 251.2 Million NOK | 5.78% |
| 2021 Q3 | 263.77 Million NOK | 5.01% |
| 2021 Q4 | 284.11 Million NOK | 7.71% |
| 2020 Q1 | 91.74 Million NOK | 18.21% |
| 2020 Q3 | 120.46 Million NOK | 6.91% |
| 2020 Q2 | 112.68 Million NOK | 22.82% |
| 2020 Q4 | 221.91 Million NOK | 84.21% |
| 2020 FY | 221.91 Million NOK | 185.94% |
| 2019 Q2 | 73.21 Million NOK | -4.75% |
| 2019 Q3 | 77.47 Million NOK | 5.83% |
| 2019 FY | 77.6 Million NOK | 14.11% |
| 2019 Q4 | 77.6 Million NOK | 0.17% |
| 2019 Q1 | 76.85 Million NOK | 13.0% |
| 2018 Q1 | 51.2 Million NOK | -16.99% |
| 2018 Q2 | 66.86 Million NOK | 30.59% |
| 2018 Q3 | 68.46 Million NOK | 2.4% |
| 2018 FY | 68.01 Million NOK | 10.26% |
| 2018 Q4 | 68.01 Million NOK | -0.66% |
| 2017 FY | 61.68 Million NOK | -28.14% |
| 2017 Q4 | 61.68 Million NOK | -8.71% |
| 2017 Q3 | 67.56 Million NOK | -8.42% |
| 2017 Q2 | 73.77 Million NOK | -4.57% |
| 2017 Q1 | 77.31 Million NOK | -9.93% |
| 2016 Q4 | 85.83 Million NOK | -3.5% |
| 2016 FY | 85.83 Million NOK | -15.08% |
| 2016 Q2 | 91.14 Million NOK | -2.27% |
| 2016 Q1 | 93.26 Million NOK | -7.73% |
| 2016 Q3 | 88.94 Million NOK | -2.41% |
| 2015 Q2 | 106.56 Million NOK | 2.65% |
| 2015 Q3 | 105.4 Million NOK | -1.09% |
| 2015 Q1 | 103.81 Million NOK | -6.58% |
| 2015 Q4 | 101.07 Million NOK | -4.11% |
| 2015 FY | 101.07 Million NOK | -9.05% |
| 2014 Q1 | 45.75 Million NOK | -14.92% |
| 2014 Q3 | 112.18 Million NOK | -3.53% |
| 2014 Q4 | 111.13 Million NOK | -0.94% |
| 2014 Q2 | 116.29 Million NOK | 154.15% |
| 2014 FY | 111.13 Million NOK | 106.64% |
| 2013 Q1 | 68.81 Million NOK | 113.45% |
| 2013 FY | 53.78 Million NOK | 66.83% |
| 2013 Q4 | 53.78 Million NOK | -6.18% |
| 2013 Q3 | 57.32 Million NOK | -8.16% |
| 2013 Q2 | 62.41 Million NOK | -9.29% |
| 2012 Q1 | 51.47 Million NOK | -8.79% |
| 2012 FY | 32.23 Million NOK | -42.89% |
| 2012 Q2 | 43.38 Million NOK | -15.73% |
| 2012 Q3 | 37.14 Million NOK | -14.37% |
| 2012 Q4 | 32.23 Million NOK | -13.22% |
| 2011 Q1 | 72.63 Million NOK | 5.31% |
| 2011 Q2 | 64.24 Million NOK | -11.55% |
| 2011 Q3 | 61.98 Million NOK | -3.51% |
| 2011 Q4 | 56.44 Million NOK | -8.95% |
| 2011 FY | 56.44 Million NOK | -18.17% |
| 2010 Q4 | 68.97 Million NOK | 0.0% |
| 2010 FY | 68.97 Million NOK | -25.19% |
| 2009 FY | 92.2 Million NOK | -50.9% |
| 2008 FY | 187.76 Million NOK | -14.47% |
| 2007 FY | 219.53 Million NOK | 77.41% |
| 2006 FY | 123.74 Million NOK | -11.98% |
| 2005 FY | 140.59 Million NOK | 140.0% |
| 2004 FY | 58.57 Million NOK | -10.55% |
| 2003 FY | 65.48 Million NOK | 757.74% |
| 2002 FY | 7.63 Million NOK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Arctic Bioscience AS | 300.25 Million NOK | -13.013% |
| Aqua Bio Technology ASA | 34.42 Million NOK | -885.559% |
| BerGenBio ASA | 174.33 Million NOK | -94.638% |
| Hofseth BioCare ASA | 390.11 Million NOK | 13.021% |
| PCI Biotech Holding ASA | 44.05 Million NOK | -670.313% |
| Thor Medical ASA | 330.83 Million NOK | -2.566% |
| Ultimovacs ASA | 349.03 Million NOK | 2.784% |